trending Market Intelligence /marketintelligence/en/news-insights/trending/RL3ShfUIaJhcq38WWICqZg2 content esgSubNav
In This List

Aclaris Therapeutics acquires privately held biotechnology company

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Aclaris Therapeutics acquires privately held biotechnology company

Aclaris Therapeutics Inc. acquired privately held biotechnology company Confluence Life Sciences Inc. for $10 million in cash and 350,000 shares of the company valued at $10 million.

Confluence is focused on the discovery and development of kinase inhibitors to treat inflammatory and immunological disorders and cancer.